Cite
Guell J, Behndig A, Pleyer U, et al. Systemic exposure to intracameral vs topical mydriatic agents: in cataract surgery. Clin Ophthalmol. 2019;13:811-819doi: 10.2147/OPTH.S189671.
Guell, J., Behndig, A., Pleyer, U., Jaulerry, S., Rozot, P., Pisella, P. J., Robert, P. Y., Lanzl, I., Pourjavan, S., Aguiar, C., Fernandez, J., Grabner, G., Mencucci, R., Chiambaretta, F., & Labetoulle, M. (2019). Systemic exposure to intracameral vs topical mydriatic agents: in cataract surgery. Clinical ophthalmology (Auckland, N.Z.), 13811-819. https://doi.org/10.2147/OPTH.S189671
Guell, Jose, et al. "Systemic exposure to intracameral vs topical mydriatic agents: in cataract surgery." Clinical ophthalmology (Auckland, N.Z.) vol. 13 (2019): 811-819. doi: https://doi.org/10.2147/OPTH.S189671
Guell J, Behndig A, Pleyer U, Jaulerry S, Rozot P, Pisella PJ, Robert PY, Lanzl I, Pourjavan S, Aguiar C, Fernandez J, Grabner G, Mencucci R, Chiambaretta F, Labetoulle M. Systemic exposure to intracameral vs topical mydriatic agents: in cataract surgery. Clin Ophthalmol. 2019 May 03;13:811-819. doi: 10.2147/OPTH.S189671. eCollection 2019. PMID: 31118559; PMCID: PMC6501990.
Copy
Download .nbib